Literature DB >> 6871231

The cytochrome b and flavin content and properties of the O2- -forming NADPH oxidase solubilized from activated neutrophils.

P Bellavite, A R Cross, M C Serra, A Davoli, O T Jones, F Rossi.   

Abstract

NADPH-dependent O2- -generating activity was extracted and partially purified from guinea pig polymorphonuclear leukocytes. The most active preparation generated 202.8 nmol O2- min/min per mg protein. This activity was 30-fold higher than that of extracts from resting cells, indicating that the activated state of the oxidase was retained after solubilization. The solubilization and purification of the enzyme activity were followed by a parallel solubilization and purification of cytochrome b. Spectroscopic studies showed that solubilized cytochrome b has an Em of -245 mV and binds CO to about 30%. Cytochrome b was reduced by NADPH in anaerobiosis at a low rate and was rapidly reoxidized by air. A correlation was found between the inhibition of O2- formation caused by the SH reagent p-chloromercuribenzoate and the alterations induced by this compound on the Em of cytochrome b. These observations strongly support the participation of cytochrome b in the catalytic activity of the solubilized NADPH oxidase. The enzyme preparations contained FAD, which was found to be associated both with NADPH oxidase and with diaphorase activities. The fraction with the highest O2- forming activity contained FAD and cytochrome b in a ratio of about 0.5:1. The participation of FAD in the electron transport from NADPH to O2 is supported also by the inhibitory effect exerted by quinacrine on O2- formation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6871231     DOI: 10.1016/0167-4838(83)90008-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

Review 1.  Isolation of the respiratory burst oxidase: the role of a flavoprotein component.

Authors:  J F Parkinson; T G Gabig
Journal:  J Bioenerg Biomembr       Date:  1988-12       Impact factor: 2.945

Review 2.  Subcellular localization and dynamics of components of the respiratory burst oxidase.

Authors:  N Borregaard
Journal:  J Bioenerg Biomembr       Date:  1988-12       Impact factor: 2.945

3.  Kinetic studies of the reduction of neutrophil cytochrome b-558 by dithionite.

Authors:  I Aviram; M Sharabani
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857

4.  Composition of partially purified NADPH oxidase from pig neutrophils.

Authors:  P Bellavite; O T Jones; A R Cross; E Papini; F Rossi
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

5.  Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000.

Authors:  C A Parkos; R A Allen; C G Cochrane; A J Jesaitis
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

6.  Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase.

Authors:  R M Clancy; J Leszczynska-Piziak; S B Abramson
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

Review 7.  The NADPH oxidase of professional phagocytes--prototype of the NOX electron transport chain systems.

Authors:  Andrew R Cross; Anthony W Segal
Journal:  Biochim Biophys Acta       Date:  2004-06-28

8.  Purification of cytochrome b-245 from human neutrophils.

Authors:  A M Harper; M J Dunne; A W Segal
Journal:  Biochem J       Date:  1984-04-15       Impact factor: 3.857

9.  The superoxide-generating oxidase of leucocytes. NADPH-dependent reduction of flavin and cytochrome b in solubilized preparations.

Authors:  A R Cross; J F Parkinson; O T Jones
Journal:  Biochem J       Date:  1984-10-15       Impact factor: 3.857

10.  Constitutive NADPH-dependent electron transferase activity of the Nox4 dehydrogenase domain.

Authors:  Yukio Nisimoto; Heather M Jackson; Hisamitsu Ogawa; Tsukasa Kawahara; J David Lambeth
Journal:  Biochemistry       Date:  2010-03-23       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.